Search This Blog

Monday, June 5, 2023

Biogen, Denali halt trial for Parkinson's disease drug

 Denali Therapeutics (DNLI) announced Monday that the company and partner Biogen (BIIB) would halt a Phase 3 trial for Parkinson's disease

https://seekingalpha.com/news/3977588-biogen-denali-halt-trial-parkinsons-disease-drug

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.